Buckley Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Buckley Wealth Management, LLC

$319 Million
Q3 2024

A detailed history of Buckley Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Buckley Wealth Management, LLC holds 9,622 shares of BMY stock, worth $554,708. This represents 0.16% of its overall portfolio holdings.

Number of Shares

9,622

Previous 14,232 32.39%

Holding current value

$554,708

Previous $591,000 15.91%

% of portfolio

0.16%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$39.66 - $51.75 $182,832 - $238,567	-4,610 Reduced 32.39%	9,622 $497,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $60,375 - $79,485	-1,500 Reduced 9.53%	14,232 $591,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $41,742 - $47,328	-870 Reduced 5.24%	15,732 $853,000
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $470,062 - $560,913	-9,696 Reduced 36.87%	16,602 $851,000
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $8,451 - $9,450	-146 Reduced 0.55%	26,298 $1.53 Million
Q2 2023 Jul 11, 2023	BUY	$63.71 - $70.74 $117,672 - $130,656	1,847 Added 7.51%	26,444 $1.69 Million
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $14,521 - $16,471	-221 Reduced 0.89%	24,597 $1.7 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $294,327 - $348,524	4,298 Added 20.95%	24,818 $1.79 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $18 - $10,757	-140 Reduced 0.68%	20,520 $1.46 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $36,310 - $39,990	-500 Reduced 2.36%	20,660 $1.59 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $149,580 - $179,360	-2,433 Reduced 10.31%	21,160 $1.55 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $13,407 - $15,630	-250 Reduced 1.05%	23,593 $1.47 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $326,461 - $369,941	5,654 Added 31.08%	23,843 $1.48 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $175,161 - $194,102	3,050 Added 20.15%	18,189 $1.1 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $45,500 - $53,194	830 Added 5.8%	15,139 $890,000
Q1 2020 Apr 10, 2020	SELL	$46.4 - $67.43 $36,563 - $53,134	-788 Reduced 5.22%	14,309 $798,000
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $210,963 - $275,182	4,287 Added 39.66%	15,097 $969,000
Q3 2019 Oct 11, 2019	BUY	$42.77 - $50.71 $94,094 - $111,562	2,200 Added 25.55%	10,810 $548,000
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $75,497 - $83,483	1,692 Added 24.46%	8,610 $390,000
Q1 2019 Apr 11, 2019	BUY	$45.12 - $53.8 $67,680 - $80,700	1,500 Added 27.69%	6,918 $330,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $9,361 - $12,140	-192 Reduced 3.42%	5,418 $282,000
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $137,975 - $155,625	-2,500 Reduced 30.83%	5,610 $348,000
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $176,855 - $220,430	-3,500 Reduced 30.15%	8,110 $449,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $155,792 - $179,348	-2,600 Reduced 18.3%	11,610 $734,000
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $851,747 - $928,623	14,210	14,210 $871,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckley Wealth Management, LLC with notifications on news.

Account

Buckley Wealth Management, LLC Bristol Myers Squibb CO Transaction History